We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Computer Algorithms Automatically Detect Malaria in Stained Blood Smears

By LabMedica International staff writers
Posted on 10 Aug 2015
An Israeli startup company has developed a computerized platform that detects anomalies in stained blood cell samples—such as those infected by the malaria parasite—faster and more accurately than the human eye.

Sight Diagnostics or SightDx (Jerusalem, Israel) was initiated in 2011 with six million USD obtained from crowd funding and several innovation investors. More...
This funding was used by a team comprising biologists, software experts, and engineers to develop vision-based algorithms to scan and analyze blood. Analysis was based on visible characteristics such as size, shape, fluorescence intensity, and morphology.

The algorithms were set to function within SightDx's Parasight platform, a high throughput instrument suitable for batch (up to 30 samples) and asynchronous loading. It was designed to be fully automated, simple to operate, and optimized for rapid testing and analysis.

The Parasight platform consists of a scanning and analyzing device as well as a sample preparation kit containing custom-built disposable plastic cartridges to create an efficient, standardized, and uniform version of the “thin blood smear”, that is easy to prepare within 15 seconds. These cartridges require only a small drop of blood that can be obtained with a finger-stick or from a tube. Parasight reports, in under three minutes, the diagnosis (Positive/Negative), parasitemia count (number of parasites per microliter), and speciation (determination of the specific species of malaria). Results are automatically transferred to the laboratory information system.

Trials using Parasight were conducted in several hospitals in India, South Africa, and France. Results showed that it was 99% accurate in sensitivity and 98% in specificity as compared to results of about 95% for human microscopists.

“Essentially, you try to do what the human eye does,” said Joseph Joel Pollak, CEO of Sight Diagnostics. “Computer vision-based devices have a camera, and the camera takes pictures of the blood. Then, algorithms analyze the scene.”

Related Links:

Sight Diagnostics



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Serological Pipet Controller
PIPETBOY GENIUS
New
Candida Glabrata Test
ELIchrom Glabrata
New
Automated Biochemical Analyzer
iBC 900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: New research brings hope for improved early detection of pancreatic cancer (Photo courtesy of Adobe Stock)

New Biomarker Panel to Enable Early Detection of Pancreatic Cancer

Pancreatic cancer (PC) has one of the worst prognoses globally, with only 13% of diagnosed patients surviving for five years or more. In Ireland, there are about 900 cases of pancreatic cancer annually,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.